Duration of anticoagulant therapy for deep vein thrombosis and pulmonary embolism

Patient-Level Meta-analysis: Effect of Measurement Timing, Threshold, and Patient Age on Ability ofd-Dimer Testing to Assess Recurrence Risk After Unprovoked Venous Thromboembolism

(2013) James Douketis et al.   ANNALS OF INTERNAL MEDICINE

Systematic Review: Case-Fatality Rates of Recurrent Venous Thromboembolism and Major Bleeding Events Among Patients Treated for Venous Thromboembolism

(2013) Marc Carrier   ANNALS OF INTERNAL MEDICINE

Comparative Effectiveness of Warfarin and New Oral Anticoagulants for the Management of Atrial Fibrillation and Venous Thromboembolism

(2013) Soheir S. Adam et al.   ANNALS OF INTERNAL MEDICINE

Antiphospholipid antibodies and the risk of recurrence after a first episode of venous thromboembolism: a systematic review

(2013) D. Garcia et al.   BLOOD

Treatment of cancer-associated thrombosis

(2013) A. Y. Y. Lee et al.   BLOOD

New Oral Anticoagulants Increase Risk for Gastrointestinal Bleeding: A Systematic Review and Meta-analysis

(2013) I. Lisanne Holster et al.   GASTROENTEROLOGY

Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update

(2013) Gary H. Lyman et al.   JOURNAL OF CLINICAL ONCOLOGY

Tossing a coin or using common sense

(2013) S. Schulman   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

The predictive ability of bleeding risk stratification models in very old patients on vitamin K antagonist treatment for venous thromboembolism: results of the prospective collaborative EPICA study

(2013) D. Poli et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Extended Use of Dabigatran, Warfarin, or Placebo in Venous Thromboembolism

(2013) Sam Schulman et al.   NEW ENGLAND JOURNAL OF MEDICINE

All-cause and disease-related health care costs associated with recurrent venous thromboembolism

(2013) Patrick Lefebvre et al.   THROMBOSIS AND HAEMOSTASIS

Efficacy and safety outcomes of oral anticoagulants and antiplatelet drugs in the secondary prevention of venous thromboembolism: systematic review and network meta-analysis

(2013) L. A. Castellucci et al.   BMJ-British Medical Journal

Importance of clarifying patients' desired role in shared decision making to match their level of engagement with their preferences

(2013) M. C. Politi et al.   BMJ-British Medical Journal

Estimating Quality of Life in Acute Venous Thrombosis

(2013) Kerstin Hogg et al.   JAMA Internal Medicine

Development of a Clinical Prediction Rule for Risk Stratification of Recurrent Venous Thromboembolism in Patients With Cancer-Associated Venous Thromboembolism

(2012) Martha L. Louzada et al.   CIRCULATION

Influence of hereditary or acquired thrombophilias on the treatment of venous thromboembolism

(2012) Clive Kearon   CURRENT OPINION IN HEMATOLOGY

Predicting disease recurrence in patients with previous unprovoked venous thromboembolism: a proposed prediction score (DASH)

(2012) A. TOSETTO et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

A conceptual framework for two phases of anticoagulant treatment of venous thromboembolism

(2012) C. KEARON   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Duration of anticoagulant therapy after a first episode of an unprovoked pulmonary embolus or deep vein thrombosis: guidance from the SSC of the ISTH

(2012) T. BAGLIN et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Prospective, multicenter validation of prediction scores for major bleeding in elderly patients with venous thromboembolism

(2012) N. Scherz et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer

(2012) D. FARGE et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Low-Dose Aspirin for Preventing Recurrent Venous Thromboembolism

(2012) Timothy A. Brighton et al.   NEW ENGLAND JOURNAL OF MEDICINE

Aspirin for Preventing the Recurrence of Venous Thromboembolism

(2012) Cecilia Becattini et al.   NEW ENGLAND JOURNAL OF MEDICINE

Apixaban for Extended Treatment of Venous Thromboembolism

(2012) Giancarlo Agnelli et al.   NEW ENGLAND JOURNAL OF MEDICINE

The treatment of venous thromboembolism with low-molecular-weight heparins

(2012) Rafal Nizankowski et al.   THROMBOSIS AND HAEMOSTASIS

Efficacy and safety of novel oral anticoagulants for treatment of acute venous thromboembolism: direct and adjusted indirect meta-analysis of randomised controlled trials

(2012) B. D. Fox et al.   BMJ-British Medical Journal

Residual vein obstruction to predict the risk of recurrent venous thromboembolism in patients with deep vein thrombosis: a systematic review and meta-analysis

(2011) M. CARRIER et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

The Post-Thrombotic Syndrome

(2011) S. R. Kahn   Hematology-American Society of Hematology Education Program

Risk of Recurrence After a First Episode of Symptomatic Venous Thromboembolism Provoked by a Transient Risk Factor

(2010) Alfonso Iorio et al.   ARCHIVES OF INTERNAL MEDICINE

Risk Assessment of Recurrence in Patients With Unprovoked Deep Vein Thrombosis or Pulmonary Embolism

(2010) Sabine Eichinger et al.   CIRCULATION

Does the clinical presentation and extent of venous thrombosis predict likelihood and type of recurrence? A patient-level meta-analysis

(2010) T. BAGLIN et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Oral Rivaroxaban for Symptomatic Venous Thromboembolism

(2010)   NEW ENGLAND JOURNAL OF MEDICINE

Update on the predictive value of D-dimer in patients with idiopathic venous thromboembolism

(2010) Benilde Cosmi et al.   THROMBOSIS RESEARCH

Predictive Value of Factor V Leiden and Prothrombin G20210A in Adults With Venous Thromboembolism and in Family Members of Those With a Mutation

(2009) Jodi B. Segal et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapy

(2008) M. A. Rodger et al.   CANADIAN MEDICAL ASSOCIATION JOURNAL